KEY FEATURES
| Full Name | Fibrinogen |
|---|---|
| Synonym | F1; FI; Fbg; Coagulation Factor I |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 12.5-800ng/mL |
| Sensitivity | 6.1ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human FG in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human FG. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human FG and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human FG, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human FG. You can calculate the concentration of Human FG in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human FG ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 43 | 88.63 | 369.9 | 39.19 | 89.13 | 397.42 |
| Standard deviation | 2.18 | 4.95 | 19.05 | 2.28 | 3.88 | 12.84 |
| CV(%) | 5.06 | 5.58 | 5.15 | 5.83 | 4.35 | 3.23 |
RECOVERY
The recovery of Human FG spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 86-100 | 92 |
| EDTA plasma (n=8) | 88-102 | 93 |
| Cell culture media (n=8) | 88-101 | 94 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human FG in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with FG ELISA Kits
| FGA ELISA Kit | publications with FG and FGA |
| FGB ELISA Kit | publications with FG and FGB |
| F13A1 ELISA Kit | publications with FG and F13A1 |
| ITGB3 ELISA Kit | publications with FG and ITGB3 |
| ITGA2B ELISA Kit | publications with FG and ITGA2B |
| ITGB2 ELISA Kit | publications with FG and ITGB2 |
Pathways associated with FG ELISA Kit
| Common Pathway Of Fibrin Clot Formation | Common Pathway Of Fibrin Clot Formation |
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| Extracellular Matrix Organization Pathway | Extracellular Matrix Organization Pathway |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway | Formation Of Fibrin Clot (Clotting Cascade) Pathway |
| GRB2:SOS Provides Linkage To MAPK Signaling For Integrins Pathway | GRB2:SOS Provides Linkage To MAPK Signaling For Integrins Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Integrin AlphaIIb Beta3 Signaling Pathway | Integrin AlphaIIb Beta3 Signaling Pathway |
| Integrin Cell Surface Interactions Pathway | Integrin Cell Surface Interactions Pathway |
| Platelet Aggregation (Plug Formation) Pathway | Platelet Aggregation (Plug Formation) Pathway |
Diseases associated with FG ELISA Kit
| Cardiovascular Diseases | publications with FG and Cardiovascular Diseases |
| Brain Diseases | publications with FG and Brain Diseases |
| Heart Diseases | publications with FG and Heart Diseases |
| Lung Diseases | publications with FG and Lung Diseases |
| Thrombosis | publications with FG and Thrombosis |
| Inflammation | publications with FG and Inflammation |
| Liver Diseases | publications with FG and Liver Diseases |
| Kidney Diseases | publications with FG and Kidney Diseases |
| Hypertension | publications with FG and Hypertension |
| Necrosis | publications with FG and Necrosis |
Organs/Tissues associated with FG ELISA Kit
| Brain | publications with FG and Brain |
| Muscle | publications with FG and Muscle |
| Liver | publications with FG and Liver |
| Embryonic Tissue | publications with FG and Embryonic Tissue |
| Testis | publications with FG and Testis |
| Reticulum | publications with FG and Reticulum |
